Curaleaf Responds to Misleading Information from Aurora with Clear Fact Sheet

Curaleaf's Response to Aurora: Setting the Record Straight

In a pivotal moment for the cannabis industry, Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent player in both consumer and medical cannabis markets, has released a comprehensive fact sheet aimed at correcting what it considers to be misleading statements made by Aurora Cannabis Inc. regarding Curaleaf's takeover proposal. This fact sheet sheds light on several myths perpetuated by Aurora while simultaneously elucidating Curaleaf's vision for a unified future in the industry.

The fact sheet highlights the merits of Curaleaf's acquisition offer, arguing that shareholders of Aurora should focus on the realities rather than the rhetoric. Curaleaf is not just making a proposal; it is presenting a strategic opportunity that seeks to create enhanced shareholder value—a claim that Curaleaf strongly believes is substantiated by its record of success in the cannabis sector.

Addressing Common Myths

Curaleaf emphasizes that several misconceptions about its acquisition proposal need clarification. The first myth states that Curaleaf's offer undervalues Aurora. Curaleaf counters by showcasing that its offer includes one of the highest premiums observed in Canadian mergers and acquisitions, bolstered by strong operational cash flow since FY21.

Another area of contention is Aurora's assertion that its standalone strategy will yield more rewards than Curaleaf's combined approach. Curaleaf refers to the nearly six years of operating under this strategy, pointing out significant impairments and transformation costs without showing tangible results. Contrastingly, Curaleaf has generated significant positive cash flow, providing evidence of its sound financial stewardship.

Another myth challenges the value of Curaleaf's shares. Contrary to Aurora's claims, Curaleaf asserts that its stock is valued based on solid performance metrics and acknowledges a disagreement from Aurora's own advisory group regarding valuations. The fact sheet contends that Curaleaf, being a leader in revenue and cash flow generation, deserves its favorable trading position.

Curaleaf disputes another myth regarding its debt levels, articulating the distinction between manageable debt repayment and shareholder dilution. The company argues that its financial health and operational profitability justify its debt, while allowing Aurora's management to escape scrutiny over their reliance on equity issuances that dilute shareholder value.

The Future is Bright

Curaleaf's fact sheet concludes with a powerful message: the future of the cannabis industry is intertwined with the consolidation of leading companies sharing a common vision. It points to the regulatory environment favoring cannabis, emphasizing the long-term benefits that will outweigh any current misconceptions about market dynamics.

As the dialogue around the potential acquisition by Curaleaf grows, shareholders are encouraged to engage with the facts presented by Curaleaf, rather than the emotionally driven marketing rhetoric from Aurora. With possibility for significant growth and market expansion, Curaleaf invites all stakeholders to consider the long-term implications of their decisions in this ever-evolving industry.

In summary, Curaleaf’s proactive stance illustrates its commitment to transparency and shareholder engagement, fostering an environment where informed decisions can lead to fruitful outcomes for both entities involved in this potential acquisition.

For a deeper dive into the details of the fact sheet and Curaleaf's vision, visit grow.curaleaf.com.